CSIR launches Ayurvedic anti-diabetic drug BGR-34

  • BGR 34 developed jointly by NBRI & CIMAP, research units of CSIR
  • Scientifically validated for its efficacy and safety, the price is only Rs.5/- per Tablet

Pune, May 21st: A scientifically confirmed country’s first anti-diabetes Ayurvedic drug with DPP4 inhibitory activity, BGR-34 standing for Blood Glucose Regulator has been launched by Council for Scientific and Industrial Research (CSIR) today during a Press Conference in the city. BGR-34, has been designed for type 2 Diabetes mellitus and scientifically validated for its efficacy and safety mentioned Dr. A.K.S. Rawat, the Principal senior scientist, CSIR- NBRI.

Dr. Sanjeev Kumar Ojha, Senior Scientist, CSIR- NBRI, Lucknow, Dr. Dayanandan Mani, Senior Scientist, CSIR- CIMAP, Lucknow, Dr. Medha Kulkarni, Vice Principal, D Y Patil Ayurvedic College and Research Centre, Pune and S.P. Srivastav, Director, AIMIL Pharmaceuticals  (India) Ltd.

Developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), the research units of CSIR, Govt. of India situated at Lucknow, BGR-34 has been economically priced at Rs. 5 per tablet as compared to latest DPP4 inhibitors globally.

Speaking on the occasion Dr. A.K.S. Rawat, said “6 crore of the adult Indian population has been found to be diabetic and there is no effective solution for diabetes as yet. We are sure that eminent medical professionals will recommend BGR-34 to their patients suffering from type 2 Diabetes mellitus for quicker and consistent response. CSIR’s premier research institutions have developed and established the efficacy of BGR-34. The modern diabetes drugs are known for side-effects and toxicity while BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs.”

“The scientists of NBRI and CIMAP, joined hands in developing an effective, safe, patient friendly solution towards management of type 2 Diabetes mellitus. We studied in detail over 500 renowned ancient herbs and finally identified the 6 best herbs listed in Ayurvedic ancient texts for various ailments and indications. These include Daruharidra (Berberis aristata), Giloy (Tinospora cordifolia), Vijaysar (Pterocarpus marsupium), Gudmar (Gymnema Sylvestre), Majeeth (Rubia cordifoila) and Methika (Trigonella foenum-graecum). They were combined in different fractions & quantity and were processed meticulously to develop a marvellous anti-diabetic formulation. The herbs were further subjected to optimization studies to establish the right proportion”, said Dr. D.N. Mani, Senior scientist, CSIR – CIMAP.

Pre-clinical studies of this antidiabetic formulation reveals significant reduction in high blood sugar level in diabetes induced experimental subjects, with the activity being comparable with the reference standard anti-diabetic allopathic drug. Besides, the drug was found to improve LFTs, KFT’s and lipid profile significantly it also provides the much needed pronounced antioxidant protective activity. Clinical studies with BGR-34 have also revealed significant anti-diabetic activities with no untoward effects observed.

For the purpose of quality commercial production and extended distribution, AIMIL Pharmaceuticals India Limited has been transferred the rights & technical knowhow to produce and market it for medical use. The company will be manufacturing BGR-34 at its state of the art manufacturing units, which are well equipped with latest technology for manufacturing quality medicines with astringent most quality control measures.

S.P. Srivastav, Director, AIMIL, said “We are happy to be partner with institutes of such repute for passing on its benefits to the people. We have decided to launch this marvellous anti-diabetic product in the brand name BGR-34, with 34 identified active phyto-constituents from herbal resources. With a strong marketing distribution network spread all over the country, AIMIL is strongly committed to carry forward the marvellous benefits of this novel research to the suffering masses all throughout the country and abroad.”

Available on all major chemist counters of Punjab, Chandigarh and adjoining states of India, BGR-34 will now be available in Maharashtra as well. The medicine helps in regulating glucose and lipid Metabolism, reduces the chances of triopathic complications due to persistent high blood glucose and tones the functions of pancreas. It also checks over excessive thirst, urination and fatigue, imparting good quality life.